Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Larkspur Health Acquisition's enterprise value is $0.00 Mil.
Larkspur Health Acquisition's EBITDA for the trailing twelve months (TTM) ended in Sep. 2022 was $-2.52 Mil. Therefore, Larkspur Health Acquisition's EV-to-EBITDA for today is 0.00.
The historical rank and industry rank for Larkspur Health Acquisition's EV-to-EBITDA or its related term are showing as below:
LSPRW'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -38479 Med: 0 Max: 0
Current: -89.6
LSPRW's EV-to-EBITDA is not ranked
in the Diversified Financial Services industry.
Industry Median: 3.97
vs LSPRW: -89.60
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Larkspur Health Acquisition (NAS:LSPRW) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Larkspur Health Acquisition's PE Ratio (TTM) for today is calculated as:
Larkspur Health Acquisition's share price for today is $0.18.
Larkspur Health Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSPRW vs CLAY, WTMA, KACL: EV-to-EBITDA Comparison
For the Shell Companies subindustry, Larkspur Health Acquisition's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Larkspur Health Acquisition EV-to-EBITDA vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Larkspur Health Acquisition's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Larkspur Health Acquisition's EV-to-EBITDA falls into.
Larkspur Health Acquisition's current Enterprise Value is $0.00 Mil.
Larkspur Health Acquisition's EBITDA for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Larkspur Health Acquisition (LSPRW) has a EV-to-EBITDA of 0.00 as of Aug. 22, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Larkspur Health Acquisition.
Is Larkspur Health Acquisition's EV-to-EBITDA too high?
Larkspur Health Acquisition's current EV-to-EBITDA is 0.00. Overall, Larkspur Health Acquisition has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Larkspur Health Acquisition's EV-to-EBITDA compare to CLAY and WTMA?
Larkspur Health Acquisition's EV-to-EBITDA of 0.00 can be compared against companies in the Diversified Financial Services industry. The industry median EV-to-EBITDA is 3.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Diversified Financial Services company?
The median EV-to-EBITDA among Diversified Financial Services companies is 3.97, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Larkspur Health Acquisition. For the Diversified Financial Services industry, the median EV-to-EBITDA is 3.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Larkspur Health Acquisition's current EV-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Larkspur Health Acquisition stock overvalued right now?
Larkspur Health Acquisition (LSPRW) has a current EV-to-EBITDA of 0.00. The current EV-to-EBITDA is 0.00. Larkspur Health Acquisition's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Larkspur Health Acquisition (LSPRW), the current EV-to-EBITDA is 0.00 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSPRW has been successfully added to your 
